Skip to main content

Sight Sciences Inc

For the period ended Dec 31, 2024. Filed Mar 7, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 7, 2025

SGHT$11.01+9.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 16. Form 10-K Summary

None.

Exhibit Index

ExhibitNumberExhibitDescriptionFormFile No.ExhibitFiling DateFiled/ Furnished Herewith
3.1Restated Certificate of Incorporation of Sight Sciences, Inc.8-K001-405873.107/19/2021
3.2Amended and Restated Bylaws of Sight Sciences, Inc.8-K001-405873.207/19/2021
4.1Third Amended and Restated Investors' Rights Agreement, dated November 23, 2020, as amendedS-1/A333-2573204.107/08/2021
4.2Specimen Stock Certificate evidencing the shares of common stockS-1/A333-2573204.207/08/2021
4.3Description of Capital Stock10-K001-405874.33/13/2024
4.4Form of Warrant8-K001-405874.11/23/2024
10.1#Sight Sciences, Inc. 2011 Stock Incentive Plan, as amended, and U.K. sub-plan and forms of agreements thereunderS-1333-25732010.16/23/2021
10.2#Sight Sciences, Inc. 2021 Incentive Award Plan and forms of option agreements thereunderS-1/A333-25732010.207/08/2021
10.3#Sight Sciences, Inc. 2021 Incentive Award Plan Sub-Plan for UK Employees and forms of Agreements thereunder10-Q001-4058710.105/10/2022
10.4#Sight Sciences, Inc. Non-Employee Director Compensation Program*
10.5#Sight Sciences, Inc. 2021 Employee Stock Purchase PlanS-1/A333-25732010.407/08/2021
10.6#Form of Indemnification Agreement for Directors and OfficersS-1/A333-25732010.507/08/2021
10.7#Employment Agreement between Sight Sciences, Inc. and Paul Badawi, dated July 7, 2021S-1/A333-25732010.1107/08/2021
10.8#Employment Agreement between Sight Sciences, Inc. and David Badawi, M.D., dated July 7, 2021S-1/A333-25732010.1407/08/2021
10.9#Employment Agreement between Sight Sciences, Inc. and Jeremy Hayden, dated July 7, 202110-K0001-4058710.103/16/2023
10.10#Employment Agreement between Sight Sciences, Inc. and Alison Bauerlein, dated April 3, 202310-Q001-4058710.15/8/2023
10.11#Employment Agreement between Sight Sciences, Inc. and Matthew Link, dated September 11, 202310-Q001-4058710.211/07/2023
10.12#Employment Agreement between Sight Sciences, Inc. and Brenton Taylor, effective as of November 4, 2024*
10.13#Employment Agreement between Sight Sciences, Inc. and Manohar K Raheja, effective as of November 4, 2024*
10.14Multi-Tenant Space Lease between Sight Sciences and Deerfield Campbell, LLC, dated February 5, 2021.S-1333-25732010.706/23/2021
10.15First Amendment to Multi-Tenant Space Lease between Sight Sciences and Deerfield Campbell, LLC, dated December 15, 202310-K001-4058710.143/13/2024
10.16Supply Agreement between Sight Sciences, Inc. and Peter's Technology (Suzhou CO., LTD., dated January 14, 2021S-1333-25732010.1006/23/2021
10.17+Amendment #1 to Supply Agreement between Sight Sciences, Inc. and Peter's Technology (Suzhou) CO. LTD., dated January 28, 202210-K001-4058710.1503/24/2022
10.18+Amendment #2 to Supply Agreement between Sight Sciences, Inc. and Peter's Technology (Suzhou) CO. LTD., dated July 19, 202210-Q001-4058710.111/10/2022
10.19+Loan and Security Agreement, by and among Sight Sciences, Inc., and certain affiliates of Hercules Capital Inc., and Hercules Capital Inc., dated January 22, 20248-K001-4058710.11/23/2024
19.1Sight Sciences, Inc. Insider Trading Compliance Policy*
21.1Subsidiaries of Sight Sciences, Inc.10-K001-4058721.13/13/2024
23.1Consent of Deloitte & Touche LLP*
24.1Power of Attorney*
31.1Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) under the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act*
31.2Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) under the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act*
32.1Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350 , as adopted pursuant to Section 906 of the Sarbanes-Oxley Act**
32.2Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350 , as adopted pursuant to Section 906 of the Sarbanes-Oxley Act**
97.1Sight Sciences, Inc. Policy for Recovery of Erroneously Awarded Compensation10-K001-4058797.103/13/2024
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document*
101.SCHInline XBRL Taxonomy Extension Schema Document*
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document*
101.LABInline XBRL Taxonomy Extension Label Linkbase Document*
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document*
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*
  • Filed herewith.

** Furnished herewith.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.